Oncogenic role of SKA2 and its ceRNA network in hepatocellular carcinoma based on a comprehensive analysis

Wanxue Hu1, Xiaoyi Hu2, Yongchao Zhu1

  • 1Department of Clinical Laboratory, Hua County People's Hospital, Anyang, China.

PubMed
Abstract

Insights

High SKA2 expression in hepatocellular carcinoma (HCC) correlates with poor survival and advanced tumor stage. SKA2 acts as a competing endogenous RNA (ceRNA), influencing HCC progression through specific microRNA and long non-coding RNA interactions.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Genetic alterations drive cancer development and progression.
  • SKA2 (spindle and kinetochore associated complex subunit 2) is crucial for mitotic regulation.
  • The specific role of SKA2 in hepatocellular carcinoma (HCC) requires elucidation.

Purpose of the Study:

  • To comprehensively investigate the functional role of SKA2 in hepatocellular carcinoma (HCC).
  • To explore the association of SKA2 expression with patient survival and clinicopathological features in HCC.
  • To identify potential molecular mechanisms, including ceRNA networks, involving SKA2 in HCC.

Main Methods:

  • Utilized TCGA, TIMER, cBioPortal, and other bioinformatics tools for comprehensive analysis.
  • Analyzed SKA2 expression, overall survival (OS), and correlations with tumor stage and immune infiltration.
  • Investigated co-expressed genes, microRNA (miRNA) interactions, and long non-coding RNA (lncRNA) networks using miRWalk, TargetScanHuman8.0, miRDB, DIANA, and Cytoscape.

Main Results:

  • Elevated SKA2 expression was observed in HCC patients, correlating with worse OS and advanced tumor stage.
  • SKA2 expression was significantly associated with immune cell infiltration.
  • Identified 188 co-expressed genes involved in cell cycle and DNA replication; elucidated a ceRNA network involving SPACA6P-AS/hsa-miR-378a-5p/SKA2, SNHG14/hsa-miR-378a-5p/SKA2, and SNHG15/hsa-miR-378a-5p/SKA2.

Conclusions:

  • SKA2 is a prognostic biomarker in HCC, linked to tumor stage and immune microenvironment.
  • SKA2 functions as a competing endogenous RNA (ceRNA), playing a significant role in HCC tumorigenesis.
  • These findings provide a foundation for future therapeutic strategies targeting SKA2 in HCC.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K